• Something wrong with this record ?

Intensive Circuit Class Therapy in Patients with Relapsing-Remitting Multiple Sclerosis

J. Kocica, J. Kolcava, M. Sladeckova, P. Stourac, E. Vlckova, F. Dosbaba, J. Kratochvilova, J. Bednarik

. 2022 ; 54 (-) : jrm00267. [pub] 20220329

Language English Country Sweden

Document type Journal Article, Randomized Controlled Trial

OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fatigue and gait ability. METHODS: A total of 46 patients with relapsing-remitting MS were divided randomly into 2 groups: 23 patients (mean Expanded Disability Status Scale (EDSS) 2.33 ± 0.74) participated in an intensive 12-week course of intensive circuit class therapy, and 23 patients (mean EDSS 2.04 ± 0.63) served as a control group. The EDSS, Timed Up and Go (TUG) test and Four-Stage Balance Test (FSBT) made up the physical testing part, supplemented by questionnaires such as the Modified Fatigue Impact Scale (MFIS), 12-Item Multiple Sclerosis Walking Scale (MSWS-12), Beck Depression Inventory (BDI) and 36-Item Short Form Survey (SF-36). RESULTS: Significant improvements were found among intensive circuit class therapy-exercising patients in FSBT (p < 0.05), TUG test (p < 0.01), MFIS (p < 0.01), BDI (p < 0.05), MSWS-12 (p < 0.05) and the 3 subscales of SF-36 after 12 weeks of intensive circuit class therapy, while there were no significant changes in the control group. CONCLUSION: Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS. It has also proved to alleviate fatigue and symptoms of depression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010739
003      
CZ-PrNML
005      
20220506130331.0
007      
ta
008      
220425s2022 sw f 000 0|eng||
009      
AR
024    7_
$a 10.2340/jrm.v54.2027 $2 doi
035    __
$a (PubMed)35174869
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Kocica, Jan
245    10
$a Intensive Circuit Class Therapy in Patients with Relapsing-Remitting Multiple Sclerosis / $c J. Kocica, J. Kolcava, M. Sladeckova, P. Stourac, E. Vlckova, F. Dosbaba, J. Kratochvilova, J. Bednarik
520    9_
$a OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fatigue and gait ability. METHODS: A total of 46 patients with relapsing-remitting MS were divided randomly into 2 groups: 23 patients (mean Expanded Disability Status Scale (EDSS) 2.33 ± 0.74) participated in an intensive 12-week course of intensive circuit class therapy, and 23 patients (mean EDSS 2.04 ± 0.63) served as a control group. The EDSS, Timed Up and Go (TUG) test and Four-Stage Balance Test (FSBT) made up the physical testing part, supplemented by questionnaires such as the Modified Fatigue Impact Scale (MFIS), 12-Item Multiple Sclerosis Walking Scale (MSWS-12), Beck Depression Inventory (BDI) and 36-Item Short Form Survey (SF-36). RESULTS: Significant improvements were found among intensive circuit class therapy-exercising patients in FSBT (p < 0.05), TUG test (p < 0.01), MFIS (p < 0.01), BDI (p < 0.05), MSWS-12 (p < 0.05) and the 3 subscales of SF-36 after 12 weeks of intensive circuit class therapy, while there were no significant changes in the control group. CONCLUSION: Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS. It has also proved to alleviate fatigue and symptoms of depression.
650    12
$a terapie cvičením $7 D005081
650    _2
$a únava $x prevence a kontrola $7 D005221
650    _2
$a chůze (způsob) $x fyziologie $7 D005684
650    _2
$a lidé $7 D006801
650    12
$a relabující-remitující roztroušená skleróza $x patofyziologie $x terapie $7 D020529
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Kolcava, Jan $u Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic. kolcava.jan@fnbrno.cz
700    1_
$a Sladeckova, Michaela
700    1_
$a Stourac, Pavel
700    1_
$a Vlckova, Eva
700    1_
$a Dosbaba, Filip
700    1_
$a Kratochvilova, Jitka
700    1_
$a Bednarik, Josef
773    0_
$w MED00006894 $t Journal of rehabilitation medicine $x 1651-2081 $g Roč. 54, č. - (2022), s. jrm00267
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35174869 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130323 $b ABA008
999    __
$a ok $b bmc $g 1788736 $s 1161937
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 54 $c - $d jrm00267 $e 20220329 $i 1651-2081 $m Journal of rehabilitation medicine $n J Rehabil Med $x MED00006894
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...